SMT201500145B - Ceppo ospite batterico comprendente un gene spr mutante e avente attivita'tsp ridotta - Google Patents
Ceppo ospite batterico comprendente un gene spr mutante e avente attivita'tsp ridottaInfo
- Publication number
- SMT201500145B SMT201500145B SM201500145T SM201500145T SMT201500145B SM T201500145 B SMT201500145 B SM T201500145B SM 201500145 T SM201500145 T SM 201500145T SM 201500145 T SM201500145 T SM 201500145T SM T201500145 B SMT201500145 B SM T201500145B
- Authority
- SM
- San Marino
- Prior art keywords
- bacterial host
- host strain
- reduced activity
- spr gene
- mutant spr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1000587.4A GB201000587D0 (en) | 2010-01-14 | 2010-01-14 | Bacterial hoist strain |
| PCT/EP2011/050413 WO2011086136A1 (en) | 2010-01-14 | 2011-01-13 | Bacterial host strain comprising a mutant spr gene and having reduced tsp activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201500145B true SMT201500145B (it) | 2015-09-07 |
Family
ID=42028357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201500145T SMT201500145B (it) | 2010-01-14 | 2015-06-19 | Ceppo ospite batterico comprendente un gene spr mutante e avente attivita'tsp ridotta |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8969039B2 (xx) |
| EP (1) | EP2524043B1 (xx) |
| JP (1) | JP5896569B2 (xx) |
| KR (1) | KR101737152B1 (xx) |
| CN (2) | CN105505845A (xx) |
| AU (1) | AU2011206584B2 (xx) |
| BR (1) | BR112012017425A2 (xx) |
| CA (1) | CA2786335C (xx) |
| CY (1) | CY1116480T1 (xx) |
| DK (1) | DK2524043T3 (xx) |
| ES (1) | ES2539931T3 (xx) |
| GB (1) | GB201000587D0 (xx) |
| HK (1) | HK1177760A1 (xx) |
| HR (1) | HRP20150659T1 (xx) |
| PL (1) | PL2524043T3 (xx) |
| PT (1) | PT2524043E (xx) |
| RS (1) | RS54084B1 (xx) |
| SG (1) | SG182301A1 (xx) |
| SI (1) | SI2524043T1 (xx) |
| SM (1) | SMT201500145B (xx) |
| WO (1) | WO2011086136A1 (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN02401A (xx) | 2009-09-24 | 2015-08-21 | Ucb Pharma Sa | |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000591D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| BR112013032871B1 (pt) | 2011-07-13 | 2022-09-27 | Ucb Pharma S.A. | Cepa hospedeira bacteriana que expressa dsbc recombinante e método para produzir anticorpo ou fragmento de ligação de antígeno deste que se liga especificamente a cd154 |
| GB201208370D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Antibodies |
| GB201208367D0 (en) * | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
| EP3237432B1 (en) | 2014-12-22 | 2023-09-06 | UCB Biopharma SRL | Protein manufacture |
| TW201702380A (zh) * | 2015-02-27 | 2017-01-16 | 再生元醫藥公司 | 宿主細胞蛋白質修飾 |
| BR112018015259A2 (pt) | 2016-01-27 | 2018-12-18 | Medimmune Llc | métodos para preparação de anticorpos com um padrão de glicosilação definido |
| EP3942079A1 (en) | 2019-03-18 | 2022-01-26 | Bio-Rad ABD Serotec GmbH | Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation |
| KR20220031670A (ko) * | 2019-08-05 | 2022-03-11 | 와커 헤미 아게 | 발효 방법에서 재조합 단백질 방출용 박테리아 균주 |
| CN113462666B (zh) * | 2021-08-18 | 2023-04-07 | 杭州文德阶生物科技有限公司 | 羰基还原酶突变体及其应用 |
| SE545714C2 (en) * | 2021-09-24 | 2023-12-19 | Xbrane Biopharma Ab | Dna contructs for producing a pelb signal peptide |
| SE545694C2 (en) * | 2021-09-24 | 2023-12-05 | Xbrane Biopharma Ab | Dna construct comprising nucleotide sequences encoding amino acid sequences of certolizumab and pelb signal peptides |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
| US5264365A (en) | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
| GB9215540D0 (en) | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
| US5304472A (en) | 1992-11-20 | 1994-04-19 | Genentech, Inc. | Method of controlling polypeptide production in bacterial cells |
| US6027888A (en) | 1996-04-05 | 2000-02-22 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells |
| US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| EP1190258B1 (en) | 1999-06-29 | 2006-10-25 | Siga Technologies, Inc. | Assay for degp protease inhibitors |
| GB0006398D0 (en) | 2000-03-16 | 2000-05-03 | Novartis Ag | Organic compounds |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| AU8867501A (en) | 2000-09-01 | 2002-03-13 | Biogen Inc | Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| WO2002018446A2 (en) | 2000-09-01 | 2002-03-07 | Biogen, Inc. | Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| US7041479B2 (en) | 2000-09-06 | 2006-05-09 | The Board Of Trustess Of The Leland Stanford Junior University | Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| DK1341899T3 (da) | 2000-12-14 | 2006-04-10 | Genentech Inc | Bakterieværtsstammer |
| KR100879194B1 (ko) | 2000-12-14 | 2009-01-16 | 제넨테크, 인크. | 원핵생물에 의해 제조된 항체 및 이의 용도 |
| TWI334439B (en) | 2001-08-01 | 2010-12-11 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
| MXPA04001566A (es) | 2001-08-27 | 2004-05-17 | Genentech Inc | Un sistema para expresion y ensamblado de anticuerpos. |
| GB0124317D0 (en) | 2001-10-10 | 2001-11-28 | Celltech R&D Ltd | Biological products |
| WO2003048306A2 (en) | 2001-11-16 | 2003-06-12 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
| GB0129105D0 (en) | 2001-12-05 | 2002-01-23 | Celltech R&D Ltd | Expression control using variable intergenic sequences |
| ATE328906T1 (de) | 2002-06-28 | 2006-06-15 | Domantis Ltd | Dual-specifische liganden mit erhöhter halbwertszeit |
| GB0224082D0 (en) | 2002-10-16 | 2002-11-27 | Celltech R&D Ltd | Biological products |
| MXPA05004677A (es) | 2002-10-31 | 2005-11-17 | Genentech Inc | Metodos y composiciones para aumentar la produccion de anticuerpos. |
| US7993864B2 (en) | 2002-12-03 | 2011-08-09 | Ucb Pharma S.A. | Assay for identifying antibody producing cells |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| AU2004253868B2 (en) | 2003-06-13 | 2011-06-16 | Biogen Ma Inc. | Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof |
| CA2529819A1 (en) | 2003-06-30 | 2004-09-23 | Domantis Limited | Pegylated single domain antibodies |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| CA2533593A1 (en) | 2003-07-26 | 2005-02-10 | Biogen Idec Ma Inc. | Altered antibodies having improved antigen-binding affinity |
| GB0329681D0 (en) * | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
| WO2006033702A2 (en) | 2004-07-26 | 2006-03-30 | Biogen Idec Ma Inc. | Anti-cd154 antibodies |
| AU2005282700A1 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| GB0425534D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
| GB0520169D0 (en) | 2005-10-04 | 2005-11-09 | Celltech R&D Ltd | Biological products |
| CN103214577B (zh) | 2007-03-22 | 2015-09-02 | 生物基因Ma公司 | 特异性结合cd154的包括抗体、抗体衍生物和抗体片段在内的结合蛋白及其用途 |
| US7662587B1 (en) * | 2009-03-05 | 2010-02-16 | E. I. Du Pont De Nemours And Company | Gene knockout mutations that increase peptide production |
| IN2012DN02401A (xx) | 2009-09-24 | 2015-08-21 | Ucb Pharma Sa | |
| US8470552B2 (en) | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| KR101968766B1 (ko) | 2009-11-05 | 2019-04-12 | 제넨테크, 인크. | 이종 폴리펩티드의 분비를 위한 방법 및 조성물 |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000588D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| EP2546267A1 (en) | 2011-07-13 | 2013-01-16 | UCB Pharma S.A. | Bacterial host strain expressing recombinant DsbC |
| BR112013032871B1 (pt) | 2011-07-13 | 2022-09-27 | Ucb Pharma S.A. | Cepa hospedeira bacteriana que expressa dsbc recombinante e método para produzir anticorpo ou fragmento de ligação de antígeno deste que se liga especificamente a cd154 |
| GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
-
2010
- 2010-01-14 GB GBGB1000587.4A patent/GB201000587D0/en not_active Ceased
-
2011
- 2011-01-13 US US13/522,087 patent/US8969039B2/en active Active
- 2011-01-13 AU AU2011206584A patent/AU2011206584B2/en active Active
- 2011-01-13 EP EP11701216.1A patent/EP2524043B1/en active Active
- 2011-01-13 PL PL11701216T patent/PL2524043T3/pl unknown
- 2011-01-13 ES ES11701216.1T patent/ES2539931T3/es active Active
- 2011-01-13 RS RS20150420A patent/RS54084B1/en unknown
- 2011-01-13 CN CN201510999982.4A patent/CN105505845A/zh active Pending
- 2011-01-13 CA CA2786335A patent/CA2786335C/en active Active
- 2011-01-13 KR KR1020127021022A patent/KR101737152B1/ko active IP Right Grant
- 2011-01-13 DK DK11701216.1T patent/DK2524043T3/da active
- 2011-01-13 WO PCT/EP2011/050413 patent/WO2011086136A1/en active Application Filing
- 2011-01-13 PT PT117012161T patent/PT2524043E/pt unknown
- 2011-01-13 SG SG2012048567A patent/SG182301A1/en unknown
- 2011-01-13 CN CN201180009682.7A patent/CN102762732B/zh active Active
- 2011-01-13 JP JP2012548439A patent/JP5896569B2/ja active Active
- 2011-01-13 SI SI201130522T patent/SI2524043T1/sl unknown
- 2011-01-13 BR BR112012017425A patent/BR112012017425A2/pt not_active Application Discontinuation
-
2013
- 2013-04-17 HK HK13104687.5A patent/HK1177760A1/zh unknown
-
2015
- 2015-01-20 US US14/600,089 patent/US9587227B2/en active Active
- 2015-06-17 HR HRP20150659TT patent/HRP20150659T1/hr unknown
- 2015-06-18 CY CY20151100525T patent/CY1116480T1/el unknown
- 2015-06-19 SM SM201500145T patent/SMT201500145B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130030247A (ko) | 2013-03-26 |
| CN102762732A (zh) | 2012-10-31 |
| CA2786335A1 (en) | 2011-07-21 |
| KR101737152B1 (ko) | 2017-05-17 |
| JP2013516964A (ja) | 2013-05-16 |
| PT2524043E (pt) | 2015-07-22 |
| SG182301A1 (en) | 2012-08-30 |
| AU2011206584B2 (en) | 2016-06-09 |
| US20120295309A1 (en) | 2012-11-22 |
| EP2524043B1 (en) | 2015-03-18 |
| ES2539931T3 (es) | 2015-07-07 |
| PL2524043T3 (pl) | 2016-08-31 |
| US20150132828A1 (en) | 2015-05-14 |
| SI2524043T1 (sl) | 2015-07-31 |
| HRP20150659T1 (hr) | 2015-07-31 |
| HK1177760A1 (zh) | 2013-08-30 |
| JP5896569B2 (ja) | 2016-03-30 |
| WO2011086136A1 (en) | 2011-07-21 |
| RS54084B1 (en) | 2015-10-30 |
| US8969039B2 (en) | 2015-03-03 |
| BR112012017425A2 (pt) | 2015-09-15 |
| GB201000587D0 (en) | 2010-03-03 |
| US9587227B2 (en) | 2017-03-07 |
| CY1116480T1 (el) | 2018-03-07 |
| DK2524043T3 (da) | 2015-06-22 |
| CN105505845A (zh) | 2016-04-20 |
| EP2524043A1 (en) | 2012-11-21 |
| CA2786335C (en) | 2017-10-10 |
| CN102762732B (zh) | 2016-03-09 |
| AU2011206584A1 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201500145B (it) | Ceppo ospite batterico comprendente un gene spr mutante e avente attivita'tsp ridotta | |
| SI2523975T1 (sl) | Bakterijski gostiteljski sev, obsegajoč mutantni gen SPR in gen TSP divjega tipa | |
| HK1176943A1 (en) | Bacterial host strain expressing recombinant dsbc and having reduced tsp activity dsbc tsp | |
| ZA201200161B (en) | Aximi-205 pesticidal gene and methods for its use | |
| EP2570902A4 (en) | System for managing tasks for processing for a computer system which are tasks based on user operation, and method for displaying information related to tasks of the type | |
| AU2012267512A1 (en) | Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy | |
| EP2599866A4 (en) | NEW NUCLEIC ACID WITH ADJUVANS ACTIVITY AND ITS USE | |
| HRP20181482T1 (hr) | Bakterijski soj za rekombinantnu ekspresiju proteina, koji ima degp defektnu proteazu koja zadržava aktivnost šaperona, te "knocked out" tsp i ptr gene | |
| EP2527436A4 (en) | MUTANT OF NADH OXIDASE HAVING IMPROVED STABILITY AND USE THEREOF | |
| GB2470904B (en) | Angling data gathering and processing | |
| EP2444493A4 (en) | PROTEIN OF NOVEL PRENYLATIONENZYM ACTIVITY AND THIS CODING GEN | |
| SG10201403038SA (en) | Identification of biologically and clinically essential genes and gene pairs, and methods employing the identified genes and gene pairs | |
| SG2014009187A (en) | Dna element having the activity of enhancing foreign gene expression | |
| EP2616813A4 (en) | HOST-SUPPORTED GENETIC BIOSENSORS | |
| EP2583167A4 (en) | Metadata-based data access and control | |
| FR2960159B1 (fr) | Bioreacteur a oxygenation et lit bacterien separes. | |
| AU2010100822A4 (en) | hB4g | |
| EP2615169A4 (en) | FLAVINENE SYNTHESIS WITH FLAVONOL-8-HYDROXYLASE ACTIVITY AND ITS USE | |
| Gupta et al. | Bioinformatics Analysis of Microbial Genes Encoding Enzymes of Industrial Importance | |
| AU2008901541A0 (en) | Genetic hyperlink model | |
| AU2009901720A0 (en) | Selection Criteria Writer software | |
| IL194532A0 (en) | Plant gene promoter and its use |